Comparison of Usefulness of N-Terminal Pro-Brain Natriuretic Peptide as an Independent Predictor of Cardiac Function Among Admission Cardiac Serum Biomarkers in Patients With Anterior Wall Versus Nonanterior Wall ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

American Journal of Cardiology

Volumn 105, Issue 8, 2010, Pages 1065-1069

  Haeck, Joost D E ^a   Verouden, Niels J W ^a   Kuijt, Wichert J ^a,b   Koch, Karel T ^a   Van Straalen, Jan P ^a   Fischer, Johan ^a   Groenink, Maarten ^a   Bilodeau, Luc ^c   Tijssen, Jan G P ^a   Krucoff, Mitchell W ^b   De Winter, Robbert J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c MONTREAL HEART INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CREATINE KINASE MB; CREATININE; GADOLINIUM PENTETATE; TROPONIN T;

ACUTE HEART INFARCTION; ADULT; ANALYZER; ARTICLE; BLOOD SAMPLING; COMPARATIVE STUDY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CREATININE CLEARANCE; DIAGNOSTIC ACCURACY; EMBOLISM PREVENTION; FEMALE; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HOSPITAL ADMISSION; HUMAN; IMMUNOASSAY; INFLAMMATION; KIDNEY FUNCTION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; SERUM; ST SEGMENT ELEVATION; THROMBOEMBOLISM;

EID: 77950367546     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.12.003     Document Type: Article

References (14)

1. Kim R.J., Albert T.S., Wible J.H., Elliott M.D., Allen J.C., Lee J.C., Parker M., Napoli A., and Judd R.M. Performance of delayed-enhancement magnetic resonance imaging with gadoversetamide contrast for the detection and assessment of myocardial infarction: an international, multicenter, double-blinded, randomized trial. Circulation 117 (2008) 629-637
2. Kim R.J., Fieno D.S., Parrish T.B., Harris K., Chen E.L., Simonetti O., Bundy J., Finn J.P., Klocke F.J., and Judd R.M. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 100 (1999) 1992-2002
3. Haeck J.D., Koch K.T., Bilodeau L., van der Schaaf R.J., Henriques J.P., Vis M.M., Baan Jr. J., Van der Wal A.C., Piek J.J., Tijssen J.G., Krucoff M.W., and de Winter R.J. Randomized comparison of primary percutaneous coronary intervention with combined proximal embolic protection and thrombus aspiration versus primary percutaneous coronary intervention alone in ST-segment elevation myocardial infarction: the PREPARE (PRoximal Embolic Protection in Acute myocardial infarction and Resolution of ST-Elevation) study. JACC Cardiovasc Interv 2 (2009) 934-943
4. Haeck J.D., Kuijt W.J., Koch K.T., Bilodeau L., Henriques J.P., Rohling W.J., Baan Jr. J., Vis M.M., Nijveldt R., Van Geloven N., Groenink M., Piek J.J., Tijssen J.G., Krucoff M.W., and de Winter R.J. Infarct size and left ventricular function in the Proximal Embolic Protection in Acute myocardial infarction and Resolution of ST-segment Elevation (PREPARE) trial: ancillary cardiovascular magnetic resonance study. Heart Epub (2009 Oct 26)
5. Cockcroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31-41
6. Kim K.E., Onesti G., Ramirez O., Brest A.N., and Swartz C. Creatinine clearance in renal disease: a reappraisal. BMJ 4 (1969) 11-14
7. Cerisano G., Pucci P.D., Sulla A., Tommasi M., Raspanti S., Santoro G.M., and Antoniucci D. Relation between plasma brain natriuretic peptide, serum indexes of collagen type I turnover, and left ventricular remodeling after reperfused acute myocardial infarction. Am J Cardiol 99 (2007) 651-656
8. Garcia-Alvarez A., Sitges M., Delgado V., Ortiz J., Vidal B., Poyatos S., de Caralt T.M., Heras M., Bosch X., Azqueta M., Pare C., and Brugada J. Relation of plasma brain natriuretic peptide levels on admission for ST-elevation myocardial infarction to left ventricular end-diastolic volume six months later measured by both echocardiography and cardiac magnetic resonance. Am J Cardiol 104 (2009) 878-882
9. Hirayama A., Kusuoka H., Yamamoto H., Sakata Y., Asakura M., Higuchi Y., Mizuno H., Kashiwase K., Ueda Y., Okuyama Y., Hori M., and Kodama K. Usefulness of plasma brain natriuretic peptide concentration for predicting subsequent left ventricular remodeling after coronary angioplasty in patients with acute myocardial infarction. Am J Cardiol 98 (2006) 453-457
10. Paelinck B.P., Vrints C.J., Bax J.J., Bosmans J.M., De Hert S.G., de Roos A., and Lamb H.J. Relation of B-type natriuretic peptide early after acute myocardial infarction to left ventricular diastolic function and extent of myocardial damage determined by magnetic resonance imaging. Am J Cardiol 97 (2006) 1146-1150
11. Cochet A., Zeller M., Cottin Y., Robert-Valla C., Lalande A., L'Huilllier I., Comte A., Walker P.M., Desgres J., Wolf J.E., and Brunotte F. The extent of myocardial damage assessed by contrast-enhanced MRI is a major determinant of N-BNP concentration after myocardial infarction. Eur J Heart Fail 6 (2004) 555-560
12. Nakagawa K., Umetani K., Fujioka D., Sano K., Nakamura T., Kodama Y., Kitta Y., Ichigi Y., Kawabata K., Obata J.E., Takano H., Inobe Y., and Kugiyama K. Correlation of plasma concentrations of B-type natriuretic peptide with infarct size quantified by tomographic thallium-201 myocardial scintigraphy in asymptomatic patients with previous myocardial infarction. Circ J 68 (2004) 923-927
13. Panteghini M., Cuccia C., Bonetti G., Pagani F., Giubbini R., and Bonini E. Rapid determination of brain natriuretic peptide in patients with acute myocardial infarction. Clin Chem Lab Med 41 (2003) 164-168
14. Thiele H., Schindler K., Friedenberger J., Eitel I., Furnau G., Grebe E., Erbs S., Linke A., Mobius-Winkler S., Kivelitz D., and Schuler G. Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the randomized Leipzig immediate percutaneous coronary intervention abciximab IV versus IC in ST-elevation myocardial infarction trial. Circulation 118 (2008) 49-57